Long-term efficacy of specific subcutaneous, short-term MPL adjuvant immunotherapy over three treatment and three follow-up years, as measured by quality of life

ConclusionShort-term MPL adjuvant therapy showed good efficacy at 3  years following treatment completion and is suited to the long-term improvement of patient QoL.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research